MDC

Millions of patients each year suffer from delayed or missed diagnoses of soft tissue cancers and other conditions due to the difficulty of accurately targeting small lesions with existing image-guided tools. Current MRI-guided procedures are slow, cumbersome, and often not feasible in community hospitals, leaving many patients without timely, minimally invasive treatment options. This gap in access leads to worse outcomes, higher costs, and missed opportunities for early intervention when treatment success rates are highest.

• Strategic collaborations with Cook Medical, Siemens Healthineers, SOLIZE Partners, and Fujikura.
• Technology published in top journals, including a Best Paper Award in IEEE Transactions on Medical Robotics and Bionics (2022), and is covered by six IP filings.
• Selected as a TechCrunch Disrupt Battlefield Top 20 finalist (2024), Top 10 Oncology Solution by Healthcare Tech Outlook (2024), SOSV Top 100 in Human Health (2024), and MedTech Innovator 2023 Cohort Alumni.
• Multiple pilot sites secured, including leading academic medical centers.
• Raised $1.6M in pre-seed funding from top investors including SRI Ventures, SOSV, Reinforced Ventures, Arben Ventures, WERU Investment, and a co-founder of Intuitive Surgical. Recently signed a term sheet for a $2M lead investment toward a $4M seed round.

• 
  10+ things to know in #MiamiTech: News from One Nuclear, Fuel VC, Katalyst, Druo, LeverX, Rocketbeet, Kind Designs, Sail Wellness, UM, MDC, jobs & more - Refresh Miami

  Refresh Miami · Oct 31, 2025

  Thank you for reading Refresh Miami and supporting paywall-free news. Give Miami Day is coming up! Please support us so we can continue covering #MiamiTech